SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000518
Filing Date
2022-03-25
Accepted
2022-03-25 16:39:11
Documents
70
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20211231x10k.htm   iXBRL 10-K 1707930
2 EX-23.1 tmb-20211231xex23d1.htm EX-23.1 5228
3 EX-23.2 tmb-20211231xex23d2.htm EX-23.2 4072
4 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 18473
5 EX-32.1 tmb-20211231xex32d1.htm EX-32.1 9582
  Complete submission text file 0001410578-22-000518.txt   6744787

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20211231.xsd EX-101.SCH 53020
7 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 52593
8 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 197842
9 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 392005
10 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 342198
64 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10k_htm.xml XML 1057048
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 22771959
SIC: 2836 Biological Products, (No Diagnostic Substances)